Close

Stifel Reiterates Hold Rating on Homology Medicines (FIXX)

May 17, 2022 6:46 AM EDT Send to a Friend
Stifel analyst Dae Gon Ha reiterated a Hold rating and $4.00 price target on Homology Medicines (NASDAQ: FIXX)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login